Clinical Trial Update: A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects. [EARLY_Phase 1]

View source ↗

Summary

An early-phase, randomized, double-blind study of XTYW007 tablets for non-alcoholic fatty liver disease, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• XTYW007 Tablets

Snippet

Sponsor: Xi'an Xintong Pharmaceutical Research Co.,Ltd. | Conditions: Non-Alcoholic Fatty Liver Disease | EARLY_Phase 1 | Status: NOT_YET_RECRUITING